NCT05818683
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05818683
Title A Study of JNJ-78278343 in Combination With JNJ-63723283 (Cetrelimab) for Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
Florida Cancer Specialists RECRUITING Sarasota Florida 34232 United States Details
Start Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Washington University School Of Medicine RECRUITING St Louis Missouri 63110 United States Details
Perlmutter Cancer Center at NYU Langone Brooklyn RECRUITING Brooklyn New York 11223 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island RECRUITING Mineola New York 11501 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
Sidney Kimmel Cancer Center - Jefferson Health RECRUITING Philadelphia Pennsylvania 19107 United States Details
Icon Cancer Centre Kurralta Park RECRUITING Kurralta Park 5037 Australia Details
Macquarie University RECRUITING Macquarie University 2109 Australia Details
Peter MacCallum Cancer Centre RECRUITING Melbourne 3000 Australia Details
Princess Alexandra Hospital RECRUITING Woolloongabba 4102 Australia Details
Hosp Univ Fund Jimenez Diaz RECRUITING Madrid 28040 Spain Details
Hosp. Univ. 12 de Octubre RECRUITING Madrid 28041 Spain Details
Hosp Univ Hm Sanchinarro RECRUITING Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field